Stanford University
Showing 41-60 of 122 Results
-
Neha Shah
Clinical Assistant Professor, Medicine - Immunology & Rheumatology
BioDr Shah's clinical and research interests lie in Integrative Rheumatology, healing-oriented medicine that takes account of the whole patient, including all aspects of lifestyle. It emphasizes the therapeutic relationship between practitioner and patient, is informed by evidence, and makes use of all appropriate therapies, including those outside the realm of allopathic medicine. Specifically, she is interested in exploring the impact of diet/nutrition/botanicals on inflammation as it pertains to rheumatic diseases such as gout, rheumatoid arthritis, lupus, psoriatic arthritis and other autoimmune conditions, as well as studying the impact of other lifestyle approaches such as mindful meditation, sleep, yoga, stress reduction, etc. on disease burden and quality of life of patients with rheumatic diseases. She boarded in Lifestyle Medicine and has advanced training in Functional Medicine. Dr Shah is currently pursuing additional training in Ayurvedic Medicine.
-
Nigam H. Shah, MBBS, PhD
Professor of Medicine (Biomedical Informatics) and of Biomedical Data Science
Current Research and Scholarly InterestsWe analyze multiple types of health data (EHR, Claims, Wearables, Weblogs, and Patient blogs), to answer clinical questions, generate insights, and build predictive models for the learning health system.
-
Nirav R. Shah, MD, MPH
Adjunct Professor, Medicine - Primary Care and Population Health
BioNirav R. Shah, MD, MPH, is Senior Scholar at Stanford University’s School of Medicine. He is a distinguished healthcare leader with experience as an operator, scientist, innovator, and regulator. His expertise spans public health, public and private health insurance, and clinical operations across the continuum of care. At Stanford, Dr. Shah conducts research on improving healthcare quality and safety while lowering cost, driving adoption of digital technologies, and quantitatively evaluating the resulting value for US and international health care systems. Dr. Shah is Board-certified in Internal Medicine and is a graduate of Harvard College and Yale School of Medicine. He is an Advisor to the CDC Director, Senior Fellow of the Institute for Healthcare Improvement (IHI), independent director of STERIS plc [NYSE:STE], and trustee of the John A. Hartford Foundation. Previously, he served as Chief Operating Officer of Kaiser Permanente in Southern California, and as Commissioner of the New York State Department of Health.
-
Sumit Shah
Clinical Associate Professor, Medicine - Oncology
BioDr. Sumit Shah specializes in the management of advanced urologic malignancies such as prostate, kidney, bladder, and testicular cancers. He also serves as an investigator on numerous clinical trials, with a focus on novel immunotherapy agents. His academic interests also include digital health technologies and novel healthcare delivery services, both in the domestic and international setting. Dr. Shah graduated with distinction in biomedical engineering from Duke University, received his medical doctorate from Stanford University, and Masters in Public Health from Harvard University. He completed his internal medicine residency at the University of California, San Francisco (UCSF) where he stayed on faculty for one year before returning to Stanford for his fellowship training in medical oncology, where he now serves on the faculty.
-
Shagufta Shaheen
Clinical Assistant Professor, Medicine - Oncology
BioDr. Shaheen specializes in the gastrointestinal malignancies and she has expertise in treating neuroendocrine tumors (NETs). Following her fellowship in Hematology and Oncology, Dr Shaheen completed an advanced fellowship in Neuroendocrine tumors from Stanford University. The NET advanced fellowship is first of its kind in United State started under the leadership of Dr Pamela Kunz who is the founding Director of the Stanford Neuroendocrine Tumor Program established in 2015. After completing her advanced fellowship, Dr Shaheen joined Stanford Oncology division as Clinical Assistant Professor. Dr Shaheen is involved in further developing the neuroendocrine oncology program at Stanford which serves as a centre of excellence in the treatment of neuroendocrine tumors. Dr Shaheen is actively involved in clinical research and clinical trials. Dr Shaheen is also involved in taking care of patients admitted to the oncology service as well as resident and fellow teaching.
-
Husham Sharifi
Clinical Assistant Professor, Medicine - Pulmonary, Allergy & Critical Care Medicine
BioI am a Clinical Assistant Professor in the Division of Pulmonary, Allergy, and Critical Care Medicine in Stanford University School of Medicine. My practice includes a Lung Graft-versus-Host-Disease (GVHD) Clinic for patients with pulmonary complications after life-saving hematopoietic cell transplant. Our clinic is part of a Lung GVHD Consortium comprising Fred Hutchinson Cancer Center, University of Michigan, and MD Anderson Cancer Center. In this context I am the site co-Principal Investigator for two national clinical trials through the Lung GVHD Consortium that are funded by the National Institutes of Health, one studying the association of respiratory viruses with Lung GVHD and a second studying the diagnostic and prognostic utility of quantitative CT scans of the chest for Lung GVHD. Separately, I see patients with pulmonary complications of infection from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), including "Long COVID". I also see patients in the intensive care unit (ICU). My research applies advanced computational analysis to clinical metadata and quantitative imaging data, domains that draw on my graduate level education and postdoctoral training in engineering and bioinformatics. I strive to fuse detailed, communicative patient care with the advances of data science in medicine that I research and study.
-
Rahul P Sharma, MBBS, FRACP
Clinical Associate Professor, Medicine - Cardiovascular Medicine
Current Research and Scholarly InterestsTranscatheter valve therapies, CT valve imaging, AI and device innovation
-
Christopher Sharp, MD
Clinical Professor, Medicine - Primary Care and Population Health
Current Research and Scholarly InterestsClinical Informatics
Clinical Education
Teaching Physical Examination
Quality Improvement
Preventive Medicine -
Jonathan Shaw
Clinical Associate Professor, Medicine - Primary Care and Population Health
Clinical Associate Professor (By courtesy), Obstetrics & GynecologyCurrent Research and Scholarly InterestsPrimary care, psycho-social determinants of health & care, maternal-child health
-
Meera Sheffrin
Clinical Associate Professor, Medicine - Primary Care and Population Health
Current Research and Scholarly InterestsGeriatric education
Implementation and evaluation of home-based care
Improving care for older adults with dementia -
Bansari Sureshchandra Sheth
Adjunct Clinical Assistant Professor, Medicine - Primary Care and Population Health
BioDr. Sheth is originally from southern California, but has progressively moved up the coast over the last few years, now making the Bay Area her wonderful new home. Board certified in Family Medicine, she had comprehensive training during residency. She has a variety of special interests, including pediatric illnesses, women’s health, diabetes care including lifestyle management, as well as Hepatitis C treatment. She believes in empowering her patients, working together with them as a team. In her free time, Dr. Sheth enjoys yoga, going to plays or musicals, comedy shows, and hiking.
-
Parveen Shiraz, MD
Instructor, Medicine - Blood & Marrow Transplantation
Current Research and Scholarly InterestsI am a physician-scientist in the Division of Blood and Marrow Transplantation/Cell Therapy (BMT/CT) at Stanford University. The dearth of effective therapies for refractory leukemias and the curative potential of hematopoietic stem cell transplant (HCT) prompted me to pursue a career in HCT. As a BMT clinician, caring for patients suffering from the toxicities of HCT and post-HCT leukemia relapse motivated me to pursue laboratory and translational research in search of less toxic and more effective HCT conditioning strategies. In 2021, I became an instructor in the laboratory of Dr. Judith Shizuru who specializes in CD117 antibody based non-toxic HCT conditioning. We have produced anti-CD117 multi-antigen targeting and NK, macrophage or T cell engaging antibodies to eradicate residual leukemic clones and permit engraftment of normal donor HSCs. Our invitro studies are already showing superiority of the multiantigen targeting NK engaging antibodies and invivo studies of these antibodies in xenograft models of myelodysplastic syndrome and acute myeloid leukemia are in progress.
